- Home
- PHGE vs DATS Comparison
PHGE vs DATS Comparison
Compare PHGE & DATS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHGE
- DATS
- Stock Information
- Founded
- PHGE 2015
- DATS 2014
- Country
- PHGE Israel
- DATS United States
- Employees
- PHGE N/A
- DATS N/A
- Industry
- PHGE Biotechnology: Pharmaceutical Preparations
- DATS Computer Software: Prepackaged Software
- Sector
- PHGE Health Care
- DATS Technology
- Exchange
- PHGE Nasdaq
- DATS Nasdaq
- Market Cap
- PHGE 11.0M
- DATS 10.4M
- IPO Year
- PHGE N/A
- DATS 2021
- Fundamental
- Price
- PHGE $0.44
- DATS $2.64
- Analyst Decision
- PHGE Strong Buy
- DATS
- Analyst Count
- PHGE 1
- DATS 0
- Target Price
- PHGE $15.00
- DATS N/A
- AVG Volume (30 Days)
- PHGE 284.6K
- DATS 376.1K
- Earning Date
- PHGE 08-13-2025
- DATS 08-13-2025
- Dividend Yield
- PHGE N/A
- DATS N/A
- EPS Growth
- PHGE N/A
- DATS N/A
- EPS
- PHGE N/A
- DATS N/A
- Revenue
- PHGE N/A
- DATS $388.00
- Revenue This Year
- PHGE N/A
- DATS N/A
- Revenue Next Year
- PHGE N/A
- DATS N/A
- P/E Ratio
- PHGE N/A
- DATS N/A
- Revenue Growth
- PHGE N/A
- DATS N/A
- 52 Week Low
- PHGE $0.34
- DATS $1.01
- 52 Week High
- PHGE $3.86
- DATS $9.34
- Technical
- Relative Strength Index (RSI)
- PHGE 43.34
- DATS 49.72
- Support Level
- PHGE $0.43
- DATS $2.40
- Resistance Level
- PHGE $0.48
- DATS $2.80
- Average True Range (ATR)
- PHGE 0.05
- DATS 0.20
- MACD
- PHGE 0.00
- DATS -0.03
- Stochastic Oscillator
- PHGE 58.82
- DATS 36.73
About PHGE BiomX Inc. COmmon Stock
BiomX Inc is engaged in developing both natural and engineered phage cocktails and personalized treatments designed to target and destroy harmful bacteria in chronic diseases, including cystic fibrosis and diabetic foot osteomyelitis. It discovers and validates proprietary bacterial targets and customizes phage compositions against these targets, and applies its BOLT (BacteriOphage Lead to Treatment) platform to customize phage compositions against these targets. BX004 is its therapeutic phage product candidate under development for chronic pulmonary infections caused by Pseudomonas aeruginosa, or P. aeruginosa, a main contributor to morbidity and mortality in patients with CF. Its BX211 - Treatment of Diabetic Foot Osteomyelitis (DFO).
About DATS DatChat Inc.
DatChat Inc is a blockchain, cybersecurity, and social media company that not only focuses on protecting privacy on personal devices, but also protects user information after it is shared with others. Its mobile messaging application is called DatChat Messenger which is a free messaging application. The platform allows users to exercise control over their messages and posts.